Prothena outlines potential multi-billion dollar opportunity with birtamimab launch by 2026
Insights from Prothena's Q4 2024 call highlight 2025 milestones: pivotal trial results for birtamimab & Alzheimer's programs.
News Medical20h
Blood test for Alzheimer’s could replace costly and invasive spinal taps
Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...
Observer2d
Observer’s Guide to the L.A. Gallery and Museum Exhibitions to Check Out During Frieze
The MOCA Geffen is spotlighting two major crowd-pullers: Olafur Eliasson ’s seductive light installation OPEN, on view ...
Medical News Today6d
New test may detect Alzheimer's years before tau clumps show up in scans
Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...